Healthcare -
Biotechnology - NASDAQ - US
$ 1.5
-1.32 %
$ 22.3 M
Market Cap
-0.27
P/E
LGVN - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity LGVN - Longeveron Inc.
12.1 M
LAST VALUE
-46.86%
2 YEAR CAGR
2.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR